References
Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019, 393: 689–701.
Xu C, Gong Y, Wang Y, Chen Z. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments. Pharmacol Ther 2022, 233: 108026.
Gerasimenko A, Baldassari S, Baulac S. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy. Neurobiol Dis 2023, 182: 106144.
Okoh J, Mays J, Bacq A, Oses-Prieto JA, Tyanova S, Chen CJ. Targeted suppression of mTORC2 reduces seizures across models of epilepsy. Nat Commun 2023, 14: 7364.
Talos DM, Jacobs LM, Gourmaud S, Coto CA, Sun H, Lim KC, et al. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy. Ann Neurol 2018, 83: 311–327.
Kim JK, Cho J, Kim SH, Kang HC, Kim DS, Kim VN, et al. Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy. J Clin Invest 2019, 129: 4207–4223.
Chen CJ, Sgritta M, Mays J, Zhou H, Lucero R, Park J, et al. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency. Nat Med 2019, 25: 1684–1690.
Reynolds C, King MD, Gorman KM. The phenotypic spectrum of SCN2A-related epilepsy. Eur J Paediatr Neurol 2020, 24: 117–122.
Gong Y, Xu C, Wang S, Wang Y, Chen Z. Computerized application for epilepsy in China: Does the era of artificial intelligence comes? Acta Neurol Scand 2022, 146: 732–742.
Xu C, Zhang S, Gong Y, Nao J, Shen Y, Tan B, et al. Subicular caspase-1 contributes to pharmacoresistance in temporal lobe epilepsy. Ann Neurol 2021, 90: 377–390.
Acknowledgments
This Research Highlight was supported by grants from the National Natural Science Foundation of China (82173796 and 82374064), and the Medical and Health Research Project of Zhejiang Province, China (2021RC097).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, S., Guo, X., Huang, W. et al. mTORC2: The “Ace in the Hole” for a Broader Control of Epileptic Seizures?. Neurosci. Bull. (2024). https://doi.org/10.1007/s12264-024-01187-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12264-024-01187-1